Adults with obesity lost up to 22.5% of weight at 48 weeks with novel drug

Adults with obesity lost up to 22.5% of weight at 48 weeks with novel drug

January 27, 2026 2 min read Add topic to email alerts …

Continue Reading
Stop Making These 3 Mistakes When You Discontinue a GLP-1 Drug

Stop Making These 3 Mistakes When You Discontinue a GLP-1 Drug

A new study found people lost an average of 32.4 pounds while on semaglutide and tirzepatide.…

Continue Reading
Anti-Aging Drug Regrows Knee Cartilage in Major Breakthrough That Could End Knee Replacements

Anti-Aging Drug Regrows Knee Cartilage in Major Breakthrough That Could End Knee Replacements

The knee joint of a young mouse (right), aged mouse (middle) and treated aged mouse (left)…

Continue Reading
Wegovy Pill Becomes First Oral GLP-1 Weight-Loss Drug Approved in U.S.

Wegovy Pill Becomes First Oral GLP-1 Weight-Loss Drug Approved in U.S.

December 23, 2025 3 min read Add Us On GoogleAdd SciAm U.S. Approves Wegovy Weight-Loss Pill,…

Continue Reading
New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight

New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight

An experimental obesity drug called retatrutide that targets GLP-1 and two other hormones helped people lose…

Continue Reading
Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks – National

Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks – National

Negotiations that could have led to coverage of weight-loss drug Wegovy under Canadian public health plans…

Continue Reading